290 related articles for article (PubMed ID: 11891614)
1. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
Lung; 2001; 179(4):233-43. PubMed ID: 11891614
[TBL] [Abstract][Full Text] [Related]
2. Effect of nebulized epoprostenol (prostacyclin) on exhaled nitric oxide in patients with pulmonary hypertension due to congenital heart disease and in normal controls.
Forrest IA; Small T; Corris PA
Clin Sci (Lond); 1999 Jul; 97(1):99-102. PubMed ID: 10369800
[TBL] [Abstract][Full Text] [Related]
3. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
[TBL] [Abstract][Full Text] [Related]
4. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
5. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol.
Oikawa M; Kagaya Y; Otani H; Sakuma M; Demachi J; Suzuki J; Takahashi T; Nawata J; Ido T; Watanabe J; Shirato K
J Am Coll Cardiol; 2005 Jun; 45(11):1849-55. PubMed ID: 15936618
[TBL] [Abstract][Full Text] [Related]
6. Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets.
Dani C; Pavoni V; Corsini I; Longini M; Gori G; Giannesello L; Perna A; Gritti G; Paternostro F; Forestieri A; Buonocore G; Rubaltelli FF
Pediatr Pulmonol; 2007 Nov; 42(11):1048-56. PubMed ID: 17902148
[TBL] [Abstract][Full Text] [Related]
7. Epoprostenol therapy for primary pulmonary hypertension.
Cheever KH; Kitzes B; Genthner D
Crit Care Nurse; 1999 Aug; 19(4):20-7. PubMed ID: 10614244
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
Gomberg-Maitland M; Preston IR
Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
[TBL] [Abstract][Full Text] [Related]
11. Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension.
Carratu P; Scoditti C; Maniscalco M; Seccia TM; Di Gioia G; Gadaleta F; Cardone RA; Dragonieri S; Pierucci P; Spanevello A; Resta O
BMC Pulm Med; 2008 Sep; 8():20. PubMed ID: 18822124
[TBL] [Abstract][Full Text] [Related]
12. Oxidant stress but not thromboxane decreases with epoprostenol therapy.
Robbins IM; Morrow JD; Christman BW
Free Radic Biol Med; 2005 Mar; 38(5):568-74. PubMed ID: 15683712
[TBL] [Abstract][Full Text] [Related]
13. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report.
Badalian SS; Silverman RK; Aubry RH; Longo J
J Reprod Med; 2000 Feb; 45(2):149-52. PubMed ID: 10710749
[TBL] [Abstract][Full Text] [Related]
14. Clinical management of portopulmonary hypertension.
Tam NL; He XS
Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):464-9. PubMed ID: 17897906
[TBL] [Abstract][Full Text] [Related]
15. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.
Haché M; Denault A; Bélisle S; Robitaille D; Couture P; Sheridan P; Pellerin M; Babin D; Noël N; Guertin MC; Martineau R; Dupuis J
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):642-9. PubMed ID: 12658208
[TBL] [Abstract][Full Text] [Related]
16. Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension.
Ziesche R; Petkov V; Wittmann K; Kopatschka J; Stiebellehner L; Schenk P; Germann P; Röder G; Ullrich R; Block LH
Heart; 2000 Apr; 83(4):406-9. PubMed ID: 10722538
[TBL] [Abstract][Full Text] [Related]
17. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
Reddy MT; Patel H; Ventura HO
Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
[No Abstract] [Full Text] [Related]
18. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study.
Fattouch K; Sbraga F; Sampognaro R; Bianco G; Gucciardo M; Lavalle C; Vizza CD; Fedele F; Ruvolo G
J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):119-23. PubMed ID: 16645371
[TBL] [Abstract][Full Text] [Related]
19. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
[TBL] [Abstract][Full Text] [Related]
20. Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation.
Molmenti EP; Ramsay M; Ramsay K; Lynch K; Tillmann Hein HA; Molmenti H; Levy M; Goldstein R; Ausloos K; East C; Fasola C; Jung G; Escobar J; Klintmalm G
Transplant Proc; 2001; 33(1-2):1332. PubMed ID: 11267313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
